Caution: The iLet® Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use. Not...
PRESS RELEASE April 30, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that the...
IRVINE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Company reports strong revenue growth of 22%...
First novel, nonstimulant option for adults with ADHD in 20 yearsADHD affects an estimated 10 million adults in the U.S.ROCKVILLE,...
ORGOVYX® is the first and only oral androgen deprivation therapy for advanced hormone-sensitive prostate cancer in EuropeMyovant expects to secure...
CARLSBAD, Calif, April 29, 2022 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE...
The study achieved the primary endpoint of reduction in nodule hardness at 12 months and secondary endpoint of reduction in...
VANCOUVER, BC / ACCESSWIRE / April 29, 2022 / Lotus Ventures Inc. (CSE:J)(OTC PINK:LTTSF) ("Lotus" or the "Company"), a premium...
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 29, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), will report financial...
FDA-cleared HeartKey® 2.0 launches to power next generation of medical and consumer devices and platforms SAN FRANCISCO--(BUSINESS WIRE)--Global heart health...
This acquisition further underscores HST’s longstanding commitment to enhancing ASC technology and delivering improved patient outcomes across the industry. NASHVILLE--(BUSINESS...
The filing follows the European Medicines Agency's Committee for Medicinal Products for Human Use recent decision to adopt a positive...
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses...
This replaces and corrects a release that ran earlier in the week.KITCHENER, ON / ACCESSWIRE / April 29, 2022 /...
REDWOOD CITY, CA / ACCESSWIRE / April 29, 2022 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first...
ORLANDO, FL / ACCESSWIRE / April 29, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced...
JACKSON CENTER, PA / ACCESSWIRE / April 29, 2022 / A key member of Halberd Corporation's (OTC PINK:HALB) Research Team,...
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell...